Twist Bioscience dismisses PwC, appoints EY as independent auditor

Twist Bioscience Corp

PwC dismissed as auditor on March 3, 2022; its FY2020 and FY2021 audit reports were unqualified.
No disagreements with PwC on accounting principles or scope; material weaknesses in internal controls previously disclosed.
EY appointed as new auditor for FY2022 ending September 30, 2022, after audit committee selection process.
Previously reported material weaknesses include segregation of duties, revenue accuracy, and IT general controls.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.